Institutional investors purchased a net $9.1 million shares of OPK during the quarter ended September 2016. This may signal that the smart money is gaining interest in this company as the 23.47% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 6.0 Million shares of OPKO Health Inc
THE VANGUARD GROUP, INC. Bought 1.4 Million shares of OPKO Health Inc
RENAISSANCE TECHNOLOGIES LLC Bought 1.4 Million shares of OPKO Health Inc